Evidence map›Paper›PMID 12843077›Full record

ArticleJournal of clinical microbiology2003

Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay.

Younes Maaroufi, Corine Heymans, Jean-Marc De Bruyne, Valerie Duchateau, Hector Rodriguez-Villalobos, Michel Aoun, Françoise Crokaert

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Molecular Identification ofJournal of dentistry (Shiraz, Iran) · 2023
    Article
  5. Review
  6. Photo-Fenton and TiOMolecules (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Theranostics · 2021
    Article
  9. PCR-detectableOpen life sciences · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Emerging technologies for rapid identification of bloodstream pathogens.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Younes MaaroufiDepartment of Microbiology and Infectious Diseases, Institut Jules Bordet, 1000 Brussels, Belgium.
Corine Heymans
Jean-Marc De Bruyne
Valerie Duchateau
Hector Rodriguez-Villalobos
Michel Aoun
Françoise Crokaert
Institut Jules Bordet · BEErasmus Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a rapid and reproducible PCR assay for quantitation of the Candida albicans ribosomal DNA (rDNA) in clinical blood samples based on the TaqMan principle (Applied Biosystems), in which a signal is generated by cleavage of a template-specific probe during amplification. We used two fluorogenic probes based on universal, fungus-specific primers, one for the detection of C. albicans species DNA and one for the detection of all Candida genus DNA. C. albicans blastoconidia mixed with whole blood in a titration experiment yielded a linear PCR signal over a range of 3 orders of magnitude. The TaqMan-based PCR assay for C. albicans exhibited a low limit of detection (5 CFU/ml of blood) and an excellent reproducibility (96 to 99%). While the C. albicans species-specific probe had 100% specificity for C. albicans, all Candida genus-specific probes cross-reacted with other organisms likely to coinfect patients with C. albicans infections. On the basis of these data, we determined the C. albicans loads with a species-specific probe from 122 blood samples from 61 hematology or oncology patients with clinically proven or suspected systemic Candida infections. Eleven positive samples exhibited a wide range of C. albicans loads, extending from 5 to 100,475 CFU/ml of blood. The sensitivity and specificity of the present assay were 100 and 97%, respectively, compared with the results of blood culture. These data indicate that the TaqMan-based PCR assay for quantitation of C. albicans with a species-specific probe provides an attractive alternative for the identification and quantitation of C. albicans rDNA in pure cultures and blood samples.

Indexed as

BloodCandida albicansCandidiasisDNA, FungalDNA, RibosomalFungemiaHumansMycological Typing TechniquesPolymerase Chain ReactionReproducibility of ResultsSpecies SpecificityTaq PolymeraseTime FactorsDNA, FungalDNA, RibosomalTaq Polymerase

Identifiers

PMID12843077
PMCPMC165319
OpenAlexW2102758617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.